Annual Gross Margin
86.54%
-1.87%-2.12%
31 December 2023
Summary:
Y-mAbs Therapeutics annual gross profit margin is currently 86.54%, with the most recent change of -1.87% (-2.12%) on 31 December 2023. During the last 3 years, it has fallen by -2.84% (-3.18%). YMAB annual gross margin is now -6.75% below its all-time high of 92.80%, reached on 31 December 2021.YMAB Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
87.82%
+1.04%+1.20%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly gross profit margin is currently 87.82%, with the most recent change of +1.04% (+1.20%) on 30 September 2024. Over the past year, it has increased by +0.75% (+0.86%). YMAB quarterly gross margin is now -10.63% below its all-time high of 98.27%, reached on 31 March 2021.YMAB Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Gross Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.1% | +0.9% |
3 y3 years | -3.2% | -6.5% |
5 y5 years | - | - |
YMAB Gross Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -6.8% | at low | -6.5% | +13.2% |
5 y | 5 years | -6.8% | at low | -10.6% | +13.2% |
alltime | all time | -6.8% | at low | -10.6% | +13.2% |
Y-mAbs Therapeutics Gross Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 87.82%(+1.2%) |
June 2024 | - | 86.78%(-2.7%) |
Mar 2024 | - | 89.23%(-2.2%) |
Dec 2023 | 86.54%(-2.1%) | 91.27%(+4.8%) |
Sept 2023 | - | 87.07%(+12.2%) |
June 2023 | - | 77.60%(-13.5%) |
Mar 2023 | - | 89.71%(-4.1%) |
Dec 2022 | 88.41% | 93.58%(+16.6%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | 80.26%(-9.3%) |
June 2022 | - | 88.52%(+7.2%) |
Mar 2022 | - | 82.54%(-2.6%) |
Dec 2021 | 92.80%(+3.8%) | 84.78%(-9.7%) |
Sept 2021 | - | 93.87%(-2.5%) |
June 2021 | - | 96.26%(-2.0%) |
Mar 2021 | - | 98.27%(+9.9%) |
Dec 2020 | 89.38% | 89.38% |
FAQ
- What is Y-mAbs Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual gross margin year-on-year change?
- What is Y-mAbs Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly gross margin year-on-year change?
What is Y-mAbs Therapeutics annual gross profit margin?
The current annual gross margin of YMAB is 86.54%
What is the all time high annual gross margin for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual gross profit margin is 92.80%
What is Y-mAbs Therapeutics annual gross margin year-on-year change?
Over the past year, YMAB annual gross profit margin has changed by -1.87% (-2.12%)
What is Y-mAbs Therapeutics quarterly gross profit margin?
The current quarterly gross margin of YMAB is 87.82%
What is the all time high quarterly gross margin for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly gross profit margin is 98.27%
What is Y-mAbs Therapeutics quarterly gross margin year-on-year change?
Over the past year, YMAB quarterly gross profit margin has changed by +0.75% (+0.86%)